You should not take Wegovy tablets if: You have a personal or family history of medullary thyroid carcinoma or MEN 2 You have a history of pancreatitis You have severe kidney or liver disease You have diabetic retinopathy You have severe gastrointestinal disease including gastroparesis You are allergic to semaglutide or any ingredient in the tablet You are pregnant, planning pregnancy, or breastfeeding You are already taking other GLP-1 medicines (Wegovy injections, Ozempic, Rybelsus) You are under 18 years of age The most common side effects affect the digestive system and are usually most noticeable when starting treatment or moving to a higher dose
Research efforts are also focused on understanding how variations in experimental design, concentration, and molecular stability may affect compound behavior across different in vitro systems
These effects, observed in animal models, have been linked to improvements in muscle physiology and cardiac performance
Obesity and type 2 diabetes: what can be unified and what needs to be individualized
El Beshlawy, A., Abd, El Raouf, Mostafa, F., Talaat, M., Isma'eel, H., Aoun, E., Hoffbrand, A